Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
AIDS Res Hum Retroviruses ; 40(1): 37-41, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37312563

ABSTRACT

HIV-1 subtype C is associated with more than half of infections in southern Brazil and has been increasing in other regions of the country. In a previous study carried out in northeastern Brazil, we found a prevalence of 4.1% of subtype C. This work investigates the origin of subtype C in the state of Bahia based on five new viral sequences. The phylogenetic analysis showed that subtype C viruses found in Bahia descend from the main lineage that circulates in other Brazilian regions.


Subject(s)
HIV Infections , HIV-1 , Humans , Phylogeny , HIV Infections/epidemiology , HIV-1/genetics , Brazil/epidemiology , Genotype
2.
Curr HIV Res ; 21(3): 213-219, 2023.
Article in English | MEDLINE | ID: mdl-37226784

ABSTRACT

INTRODUCTION: Human immunodeficiency virus (HIV) infection, the etiological agent of acquired immunodeficiency syndrome (AIDS), is a serious public health issue. Therapeutic measures have been successful in increasing the survival and improving the quality of life. However, some treatment-naive subjects living with HIV present resistance-associated mutations as a result of late diagnosis and/or mutant strain infections. The objective of this study was to identify the virus genotype and assess the antiretroviral resistance profile based on the results of HIV genotyping in treatment-naive subjects living with HIV, after six months of taking antiretroviral therapy. METHODS: This was a prospective cohort study on treatment-naive adults living with HIV attending a specialized outpatient clinic in southern Santa Catarina State, Brazil. The participants were interviewed and had blood samples drawn. The genotypic antiretroviral drug resistance profile was examined in patients with detectable viral loads. RESULTS: 65 treatment-naive subjects living with HIV were recruited for this study. After six months of taking antiretroviral therapy, resistance-associated mutations were observed in 3 (4.6%) subjects living with HIV. CONCLUSION: Subtype C was identified as the circulating subtype in southern Santa Catarina State, and L10V, K103N, A98G, and Y179D were the most common mutations found in treatment-naive subjects.


Subject(s)
Anti-HIV Agents , HIV Infections , Adult , Humans , HIV Infections/drug therapy , Prospective Studies , Quality of Life , Anti-Retroviral Agents/pharmacology , Anti-Retroviral Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Mutation , Drug Resistance, Viral/genetics , Genotype , Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use
3.
AIDS Res Hum Retroviruses ; 37(12): 913-921, 2021 12.
Article in English | MEDLINE | ID: mdl-34036794

ABSTRACT

The subtype C accounts for >50% of HIV type 1 (HIV-1) infections worldwide and it is currently the predominant viral form in South Brazil. Subtype C has been reported in all Brazilian regions; however, the phylogenetic relationship among strains circulating in those regions still remains unclear. This study aimed to investigate the origin and dynamic dispersion of HIV-1 subtype C toward Northeast Brazil. Our phylogenetic analysis suggests that most subtype C strains circulating in Brazil (99%) are descendant from the main lineage whose entrance in the country was previously described in the 1970s. According to the literature, additional introductions of subtype C were reported in the country through the Southeast region and in this study we identified another entry event that occurred most likely through the North region. Furthermore, our analysis suggests that the spread of subtype C to Brazilian Northeastern states occurred through multiple independent introductions of the main lineage that originated in South Brazil between mid-1980s and late 1990s. Despite the observation of eventual new HIV-1 subtype C introductions, our results highlight the predominance of a single lineage of this subtype in Brazil and the importance of South region in its dissemination throughout the country.


Subject(s)
HIV Infections , HIV-1 , Brazil/epidemiology , HIV Infections/epidemiology , HIV-1/genetics , Humans , Phylogeny
4.
J Neurovirol ; 27(1): 126-136, 2021 02.
Article in English | MEDLINE | ID: mdl-33462791

ABSTRACT

The transactivator of transcription (Tat) is a key HIV regulatory protein. We aimed to identify the frequency of key polymorphisms in HIV-1C compared with HIV-1B Tat protein, chiefly in the cysteine-, arginine-, and glutamine-rich domains and identify novel point mutations in HIV-1B and C sequences from Southern Brazil. This study was the first to investigate the genetic diversity and point mutations within HIV-1 Tat C in a Brazilian cohort. This was an observational, cross-sectional study, which included sequences of HIV-1B (n = 20) and HIV-1C (n = 21) from Southern Brazil. Additionally, 344 HIV-1C sequences were obtained from the Los Alamos database: 29 from Brazil and 315 from Africa, Asia, and Europe. The frequency of C31S substitution on HIV-1 Tat C in Brazil was 82% vs. 10% in the HIV-1B group (p < 0.0001). The frequency of the R57S substitution among the HIV-1C sequences from Brazil was 74% vs. 20% in HIV-1B (p = 0.004), and that of substitution Q63E in HIV-1C was 80% and 20% in HIV-1B (p < 0.0001). The mutation P60Q was more frequent in HIV-1B than in HIV-1C (55% and 6.12%, respectively, p < 0.0001)). Novel point mutations in the HIV-1C and B Tat functional domains were described. The frequency of C31S and other key point mutations in HIV-1 Tat C in Brazil were similar to those described in Africa, although lower than those in India. The Tat-B and C sequences found in Southern Brazil are consistent with biological differences and have potential implications for HIV-1 subtype pathogenesis.


Subject(s)
HIV-1/genetics , Polymorphism, Single Nucleotide/genetics , tat Gene Products, Human Immunodeficiency Virus/genetics , Adult , Brazil , Cross-Sectional Studies , Female , Humans , Male , Middle Aged
5.
J Neurovirol ; 24(6): 786-796, 2018 12.
Article in English | MEDLINE | ID: mdl-30194587

ABSTRACT

Human immunodeficiency virus (HIV) genetic compartmentalization is defined as genetic differences in HIV in different tissue compartments or subcompartments that characterize viral quasispecies. This descriptive, longitudinal study assessed the dynamics of inflammation, humoral immune response, blood-brain barrier, blood-cerebrospinal fluid (CSF) barrier, as well as neuronal injury biomarkers in serially obtained CSF and serum samples from an antiretroviral (ARV) therapy-naïve patient with HIV-1 subtype C with CSF HIV genetic compartmentalization that resolved spontaneously without ARV treatment. The first CSF sample showed an increase in white blood cell (WBC) count (382 cells/mm3) and a marked increase in the levels of inflammatory cytokines and chemokines, including tumor necrosis factor (TNF)α, interleukin (IL)-10, IP-10, and regulated on activation, normal T cell expressed and secreted (RANTES), which raise the suspicion of dual infection. Serum sample analysis showed all cytokine levels to be normal, with only IP-10 slightly increased. These results corroborate the hypothesis that the CNS immunologic response in a patient with HIV infection was independent of the systemic immunologic response. The patient also had persistently elevated levels of sCD14, neopterin, and ß2M, which were strongly suggestive of persistent CNS immunologic stimulation. This report describes a patient with HIV subtype C who developed a transient episode of asymptomatic HIV meningitis with compartmentalization of HIV in the CSF that resolved independently of ARV therapy. Extensive CSF studies were performed as part of an ongoing longitudinal study, which revealed CNS immune abnormalities. This case presents evidence of HIV-1 subtype C neurotropism and compartmentalization.


Subject(s)
AIDS Dementia Complex/cerebrospinal fluid , AIDS Dementia Complex/virology , HIV-1/physiology , Meningitis/cerebrospinal fluid , Meningitis/virology , Biomarkers/cerebrospinal fluid , Humans , Longitudinal Studies , Male , Middle Aged
6.
Chem Biol Drug Des ; 92(5): 1899-1913, 2018 11.
Article in English | MEDLINE | ID: mdl-30003668

ABSTRACT

HIV-1 protease (HIV PR) is considered as one of the most attractive targets for the treatment of HIV and the impact of flap dynamics of HIV PR on the binding affinities of protease inhibitors (PIs) is a crucial ongoing research field. Recently, our research group evaluated the binding affinities of different FDA approved PIs against the South African HIV-1 subtype C (C-SA) protease (PR). The CSA-HIV PR displayed weaker binding affinity for most of the clinical PIs compared to HIV-1 B subtype for West and Central Europe, the Americas. In the current work, the flap dynamics of four different systems of HIV-1 C-SA PR complexed to FDA approved second generation PIs and its impact on binding was explored over the molecular dynamic trajectories. It was observed that the interactions of the selected drugs with the binding site residues of the protease may not be the major contributor for affinity towards PIs. Various post-MD analyses were performed, also entropic contributions, solvation free energies and hydrophobic core formation interactions were studied to assess how the flap dynamics of C-SA PR which is affected by such factors. From these contributions, large van der Waals interactions and low solvation free energies were found to be major factors for the higher activity of ATV against C-SA HIV PR. Furthermore, a comparatively stable hydrophobic core may be responsible for higher stability of the PR flaps of the ATV complex. The outcome of this study provides significant guidance to how the flap dynamics of C-SA PR is affected by various factors as a result of the binding affinity of various protease inhibitors. It will also assist with the design of potent inhibitors against C-SA HIV PR that apart from binding in the active site of PR can interacts with the flaps to prevent opening of the flaps resulting in inactivation of the protease.


Subject(s)
HIV Protease Inhibitors/chemistry , HIV Protease/chemistry , HIV-1/enzymology , Molecular Dynamics Simulation , Binding Sites , Catalytic Domain , Genotype , HIV Protease/metabolism , HIV Protease Inhibitors/metabolism , HIV-1/genetics , Humans , Hydrogen Bonding , Principal Component Analysis , South America , Thermodynamics
7.
Infect Genet Evol ; 52: 100-105, 2017 08.
Article in English | MEDLINE | ID: mdl-28427935

ABSTRACT

Molecular epidemiology has become a key tool for tracking infectious disease epidemics. Here, the spread of the most prevalent HIV-1 subtypes in Northern Alberta, Canada, was characterized with a Bayesian phylogenetic approach using 1146 HIV-1 pol sequences collected between 2007 and 2013 for routine clinical management purposes. Available patient metadata were qualitatively interpreted and correlated with onwards transmission using Fisher exact tests and logistic regression. Most infections were from subtypes A (n=36), B (n=815) and C (n=211). Africa is the dominant origin location for subtypes A and C while the subtype B epidemic was seeded from the USA and Middle America and, from the early 1990s onwards, mostly by interprovincial spread. Subtypes A (77.8%) and C (74.0%) were usually heterosexually transmitted and circulate predominantly among Blacks (61.1% and 85% respectively). Subtype B was mostly found among Caucasians (48.6%) and First Nations (36.8%), and its modes of transmission were stratified by ethnic origin. Compared to subtypes A (5.6%) and C (3.8-10.0%), a larger portion of subtype B patients were found within putative provincial transmission networks (20.3-29.5%), and this almost doubled when focusing on nationwide transmission clusters (37.9-57.5%). No clear association between cluster membership and particular patient characteristics was found. This study reveals complex and multi-faceted transmission dynamics of the HIV-1 epidemic in this otherwise low HIV prevalence population in Northern Alberta, Canada. These findings can aid public health planning.


Subject(s)
HIV Infections/epidemiology , HIV Infections/transmission , HIV-1/classification , HIV-1/genetics , Adolescent , Adult , Africa , Aged , Alberta/epidemiology , Bayes Theorem , Central America , Female , HIV Infections/ethnology , HIV Infections/virology , Humans , Male , Middle Aged , Phylogeny , Phylogeography , Public Health , United States , Young Adult , pol Gene Products, Human Immunodeficiency Virus/genetics
8.
J Neurovirol ; 23(3): 460-473, 2017 06.
Article in English | MEDLINE | ID: mdl-28247269

ABSTRACT

Despite the effective suppression of viremia with antiretroviral therapy, HIV can still replicate in the central nervous system (CNS). This was a longitudinal study of the cerebrospinal fluid (CSF) and serum dynamics of several biomarkers related to inflammation, the blood-brain barrier, neuronal injury, and IgG intrathecal synthesis in serial samples of CSF and serum from a patient infected with HIV-1 subtype C with CNS compartmentalization.The phylogenetic analyses of plasma and CSF samples in an acute phase using next-generation sequencing and F-statistics analysis of C2-V3 haplotypes revealed distinct compartmentalized CSF viruses in paired CSF and peripheral blood mononuclear cell samples. The CSF biomarker analysis in this patient showed that symptomatic CSF escape is accompanied by CNS inflammation, high levels of cell and humoral immune biomarkers, CNS barrier dysfunction, and an increase in neuronal injury biomarkers with demyelization. Independent and isolated HIV replication can occur in the CNS, even in HIV-1 subtype C, leading to compartmentalization and development of quasispecies distinct from the peripheral plasma. These immunological aspects of the HIV CNS escape have not been described previously. To our knowledge, this is the first report of CNS HIV escape and compartmentalization in HIV-1 subtype C.


Subject(s)
Central Nervous System/virology , Encephalitis, Viral/virology , HIV Infections/virology , HIV-1/pathogenicity , Immune Evasion , RNA, Viral/cerebrospinal fluid , Adult , Anti-HIV Agents/therapeutic use , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Blood-Brain Barrier/immunology , Blood-Brain Barrier/virology , Central Nervous System/immunology , Central Nervous System/pathology , Chemokine CCL5/blood , Chemokine CCL5/cerebrospinal fluid , Encephalitis, Viral/drug therapy , Encephalitis, Viral/immunology , Encephalitis, Viral/pathology , HIV Antibodies/blood , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/pathology , HIV-1/immunology , Humans , Immunoglobulin G/blood , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/virology , Lipopolysaccharide Receptors/blood , Longitudinal Studies , Male , Myelin Basic Protein/blood , Myelin Basic Protein/cerebrospinal fluid , Neurofilament Proteins/blood , Neurofilament Proteins/cerebrospinal fluid , Phylogeny , Virus Replication
9.
J Neurovirol ; 22(6): 789-798, 2016 12.
Article in English | MEDLINE | ID: mdl-27431676

ABSTRACT

Major depressive disorder (MDD) is among the most prevalent neuropsychiatric disorders associated with HIV infection; however, its risks and neurobiologic correlates in diverse cultures are poorly understood. This study aimed to examine the frequency of MDD among HIV+ participants in southern Brazil. We hypothesized that the frequency and severity of MDD would be higher among individuals with HIV+ compared with HIV- and higher in HIV subtype B compared with C. Individuals with HIV (n = 39) as well as seronegative controls (n = 22) were enrolled in a cross-sectional, prospective, observational study. Current and lifetime history of MDD was diagnosed by MINI-Plus; symptom severity was assessed by Beck Depression Inventory-II (BDI-II). Current and past episodes of MDD were significantly more frequent in the HIV+ versus HIV- group: current MDD, 15 (38.5 %) vs. 0 (0 %), p = 0.0004; past MDD, 24 (61.5 %) vs. 3 (13.6 %), p = 0.0004. The median BDI-II score in the HIV+ group was significantly higher than that in the HIV- (13 (8-27.5) vs. 2.5 (1-5.5); p < 0.0001). Current suicide risk, defined as during the last month, was found in 18 % of participants in the HIV-positive and none in the HIV-negative group. Neither current MDD frequency (8 (57.1 %) vs. 6 (40 %), p = 0.47) nor BDI-II score differed across subtypes B and C. HIV+ group may be more likely to experience current MDD than HIV-. This was the first study to compare the frequency and severity of MDD in HIV subtypes B and C; we found no difference between HIV subtypes B and C.


Subject(s)
Depressive Disorder, Major/epidemiology , HIV Infections/epidemiology , HIV-1/classification , Suicide/statistics & numerical data , Adult , Brazil/epidemiology , Case-Control Studies , Cross-Sectional Studies , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/physiopathology , Depressive Disorder, Major/psychology , Female , HIV Infections/diagnosis , HIV Infections/physiopathology , HIV Infections/psychology , HIV-1/genetics , HIV-1/pathogenicity , Humans , Male , Middle Aged , Molecular Typing , Prevalence , Prospective Studies , Psychiatric Status Rating Scales , Risk Assessment , Severity of Illness Index , Suicide/psychology
10.
Braz. j. infect. dis ; Braz. j. infect. dis;15(4): 349-355, July-Aug. 2011. tab
Article in English | LILACS | ID: lil-595676

ABSTRACT

Southern Brazil has the highest prevalence rate of AIDS in the country and is the only region in the Americas where HIV-1 subtype C prevails. OBJECTIVE: We evaluated the epidemiologic and clinical characteristics of pregnant women living with HIV/AIDS in the South region of Santa Catarina, Brazil. METHODS: All pregnant women with HIV infection attending the obstetric outpatient clinic of Criciúma, State of Santa Catarina, in 2007 (n = 46) were invited to participate. Data of 36 eligible participants were obtained through a standardized questionnaire. RESULTS: The great majority were young, with a steady partner, low family income, low education level and referring early first sexual intercourse. Many reported use of illicit non-injecting drugs (55.5 percent) and unprotected sex with partners that were HIV-positive (57.7 percent), injecting drug user (22.2 percent), male inmate (19.4 percent), truck driver (13.8 percent), with history of sexually transmitted disease (11.1 percent) or men who have sex with men (MSM) (2.8 percent). Most (66.7 percent) of the participants had their HIV diagnosis done during the pregnancy, 7 (19.4 percent) had a previous history of HIV mother-to-child transmission. Therapy based on highly active antiretroviral therapy (94 percent) was initiated at 19.3 weeks on average and 33 percent showed irregular antiretroviral adherence. CONCLUSION: These results confirm previous data on HIV epidemiology in Brazil and suggest that the women partners' sexual behavior and unprotected sexual intercourse are important aspects of HIV epidemic. Additional efforts in education, prophylaxis and medication adherence are needed.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Pregnancy , Young Adult , HIV Infections/epidemiology , HIV-1 , Pregnancy Complications, Infectious/epidemiology , Brazil/epidemiology , Cross-Sectional Studies , HIV Infections/virology , Parity , Prevalence , Pregnancy Complications, Infectious/virology , Risk Factors , Sexual Behavior , Socioeconomic Factors
11.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;40(3): 259-263, maio-jun. 2007. tab
Article in English | LILACS | ID: lil-456315

ABSTRACT

The objective of this study was to investigate the frequency of HIV infection among female sex workers in the port area of Imbituba (State of Santa Catarina), and to identify the viral subtype and its susceptibility to antiretroviral medications. Ninety women were interviewed between December 2003 and February 2004. Six (6.7 percent) were HIV-positive. Genotyping for HIV, performed on four samples, detected subtype C in three of them, which is predominant in Africa and Asia, and subtype B in one of them, which is prevalent in Brazil, USA and Europe. The results suggest that the Port of Imbituba may be one of the gateways for HIV-1 subtype C to enter Brazil, and for its dissemination to the rest of the country and the Mercosul area, along the highway BR-101. This points towards the need for preventive work to reduce the introduction and dissemination of HIV subtype C in Brazil.


O objetivo deste estudo foi verificar a freqüência da infecção pelo HIV em profissionais do sexo, atuantes em Imbituba (SC), identificar o subtipo viral e a suscetibilidade do vírus aos medicamentos antiretrovirais. De dezembro de 2003 a fevereiro de 2004, foram entrevistadas 90 mulheres, profissionais do sexo, e a freqüência de HIV nessa população foi de 6,7 por cento. O teste de genotipagem para o HIV, realizado em quatro amostras, detectou em três delas o subtipo C, que é predominante na Africa e Asia, e em uma o subtipo B, prevalente no Brasil, EUA e Europa. Os resultados sugerem que o Porto de Imbituba pode ser uma das portas de entrada para do HIV-1 subtipo C no Brasil, e a partir dessa localidade ocorrer sua disseminação para o restante do País e países do Mercosul pela rodovia BR-101. Isto aponta para a necessidade de trabalhos de prevenção, com a finalidade de reduzir a introdução, transmissão e disseminação do HIV subtipo C.


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , HIV Infections/virology , HIV-1 , Sex Work , Anti-HIV Agents/pharmacology , Brazil/epidemiology , Genotype , HIV Infections/epidemiology , HIV-1 , Interviews as Topic , Microbial Sensitivity Tests , RNA, Viral/analysis , Socioeconomic Factors
SELECTION OF CITATIONS
SEARCH DETAIL